Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells

Cancer Research

Volumn 63, Issue 5, 2003, Pages 1083-1092

  Benckert, Christoph ^a   Jonas, Sven ^a   Cramer, Thorsten ^a   Von Marschall, Zofia ^a   Schäfer, Georgia ^a   Peters, Michael ^a   Wagner, Karola ^a   Radke, Cornelia ^a   Wiedenmann, Bertram ^a   Neuhaus, Peter ^a   Höcker, Michael ^a   Rosewicz, Stefan ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; AUTOCRINE EFFECT; BILE DUCT CARCINOMA; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MUTATIONAL ANALYSIS; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BINDING SITES; CHOLANGIOCARCINOMA; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; PROMOTER REGIONS (GENETICS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037373855     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Neuhaus, P., Jonas, S., Bechstein, W. O., Lohmann, R., Radke, C., Kling, N., Wex, C., Lobeck, H., and Hintze, R. Extended resections for hilar cholangiocarcinoma. Ann. Surg., 230: 808-818, 1999.
2. Farley, D. R., Weaver, A. L., and Nagorney, D. M. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin. Proc., 70: 425-429, 1995.
3. Bismuth, H., Nakache, R., and Diamond, T. Management strategies in resection for hilar cholangiocarcinoma. Ann. Surg., 215: 31-38, 1992.
4. Kerbel, R. S. Tumor angiogenesis: past, present and the near future. Carcinogenesis (Lond.), 21: 505-515, 2000.
5. Carmeliet, P., and Jain, R. K. Angiogenesis in cancer and other diseases. Nature (Lond.), 407: 249-257, 2000.
6. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
7. Folkman, J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
8. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
9. Ferrara, N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med., 77: 527-543. 1999.
10. Veikkola, T., and Alitalo, K. VEGFs, receptors and angiogenesis. Semin. Cancer Biol., 9: 211-220, 1999.
11. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
12. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Wash. DC), 246: 1309-1312, 1989.
13. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC), 219: 983-985, 1983.
14. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D. W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5: 1806-1814, 1991.
15. De Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Wash. DC), 255: 989-991, 1992.
16. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1992.
17. Petrova, T. V., Makinen, T., and Alitalo, K. Signaling via vascular endothelial growth factor receptors. Exp. Cell Res., 253: 117-130, 1999.
18. Pepper, M. S. Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev., 8: 21-43, 1997.
19. Massague, J., Blain, S. W., and Lo, R. S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell, 103: 295-309, 2000.
20. Blobe, G. C., Schiemann, W. P., and Lodish, H. F. Role of transforming growth factor βin human disease. N. Engl. J. Med., 342: 1350-1358, 2000.
21. Massague, J., and Wotton, D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J., 19: 1745-1754, 2000.
22. von Marschall, Z., Cramer, T., Hocker, M., Finkenzeller, G., Wiedenmann, B., and Rosewicz, S. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut, 48: 87-96, 2001.
23. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
24. von Marschall, Z., Riecken, E. O., and Rosewicz, S. Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines. Gut, 43: 692-698, 1998.
25. Finkenzeller, G., Sparacio, A., Technau, A., Marme, D., and Siemeister, G. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene, 15: 669-676, 1997.
26. Schafer, G., Cramer, T., Suske, G., Kemmner, W., Wiedenmann, B., and Hocker, M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J. Biol. Chem., 278: in press, 2003.
27. Hagen, G., Muller, S., Beato, M., and Suske, G. Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res., 20: 5519-5525, 1992.
28. Plate, K. From angiogenesis to lymphangiogenesis. Nat. Med., 7: 151-152, 2001.
29. Kawahara, N., Ono, M., Taguchi, K., Okamoto, M., Shimada, M., Takenaka, K., Hayashi, K., Mosher, D. F., Sugimachi, K., Tsuneyoshi, M., and Kuwano, M. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology, 28: 1512-1517, 1998.
30. Hida, Y., Morita, T., Fujita, M., Miyasaka, Y., Horita, S., Fujioka, Y., Nagashima, K., and Katoh, H. Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas. Anticancer Res., 19: 2257-2260, 1999.
31. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
32. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential turnout angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
33. Ikeda, E., Achen, M. G., Breier, G., and Risau, W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem., 270: 19761-19766, 1995.
34. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
35. Reeves, M. E., and DeMatteo, R. P. Genes and viruses in hepatobiliary neoplasia. Semin. Surg. Oncol., 19: 84-93, 2000.
36. Jonas, S., Springmeier, G., Tauber, R., Wiedenmann, B., Lobeck, H., Gessner, R., Kreft, B., Kling, N., Moelling, K., and Neuhaus, P. p53 mutagenesis in Klatskin tumors. Hum. Pathol., 29: 955-960, 1998.
37. Okada, F., Rak, J. W., Croix, B. S., Lieubeau. B., Kaya, M., Roncari, L., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc. Natl. Acad. Sci. USA, 95: 3609-3614, 1998.
38. Kieser, A., Weich, H. A., Brandner, G., Marine, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9: 963-969, 1994.
39. Goldman, C. K., Kim, J., Wong, W. L., King, V., Brock, T., and Gillespie, G. Y. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell, 4: 121-133, 1993.
40. Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274, 1994.
41. Grande, J. P. Role of transforming growth factor-β in tissue injury and repair. Proc. Soc. Exp. Biol. Med., 214: 27-40, 1997.
42. Border, W. A., and Noble, N. A. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med., 331: 1286-1292, 1994.
43. Oberhammer, F., Bursch, W., Parzefall, W., Breit, P., Erber, E., Stadler, M., and Schulte-Hermann, R. Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res., 51: 2478-2485, 1991.
44. Yokomuro. S., Tsuji, H., Lunz, J. G., III, Sakamoto, T., Ezure, T., Murase, N., and Demetris, A. J. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor β1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology, 32: 26-35, 2000.
45. Goggins, M., Shekher, M., Turnacioglu, K., Yeo, C. J., Hruban, R. H., and Kern, S. E. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res., 58: 5329-5332, 1998.
46. Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J. D., Neumann, A., Brattain, M. G., Chang, J., Kim, S. J., Kinzler, K. W., Vogelstein, B., Willson. J. K., and Markowitz, S. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res., 59: 320-324, 1999.
47. Dolecki, G. J., and Connolly, D. T. Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem. Biophys. Res. Commun., 180: 572-578, 1991.
48. Chua, C. C., Hamdy, R. C., and Chua, B. H. Mechanism of transforming growth factor-β1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochim. Biophys. Acta, 1497: 69-76, 2000.
49. Saadeh, P. B., Mehrara, B. J., Steinbrech, D. S., Dudziak, M. E., Greenwald, J. A., Luchs, J. S., Spector, J. A., Ueno, H., Gittes, G. K., and Longaker, M. T. Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am. J. Physiol, 277: C628-C637, 1999.
50. Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., and Werner, S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem., 270: 12607-12613, 1995.
51. De Bleser, P. J., Niki, T., Rogiers, V., and Geerts, A. Transforming growth factor-β gene expression in normal and fibrotic rat liver. J. Hepatol., 26: 886-893, 1997.
52. Vogelbruch, M., Wellmann, A., Maschek, H., Schafer, M. K., Flemming, P., and Georgii, A. Transforming growth factor β1 in human liver tumors. Verh. Dtsch. Ges. Pathol., 79: 132-136, 1995.
53. Chen, Y., Sasatomi, E., Satoh, T., Miyazaki, K., and Tokunaga, O. Abnormal distribution of collagen type IV in extrahepatic bile duct carcinoma. Pathol. Int., 50: 884-890, 2000.
54. Brogi, E., Wu, T., Namiki, A., and Isner, J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation, 90: 649-652, 1994.
55. Milanini, J., Vinals, F., Pouyssegur, J., and Pages, G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem., 273: 18165-18172, 1998.
56. Tanaka, T., Kanai, H., Sekiguchi, K., Aihara, Y., Yokoyama, T., Arai, M., Kanda, T., Nagai, R., and Kurabayashi, M. Induction of VEGF gene transcription by IL-1/β is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J. Mol. Cell Cardiol., 32: 1955-1967, 2000.
57. Sallmath, B., Marme, D., and Finkenzeller, G. Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene, 19: 3470-3476, 2000.
58. Li, J. M., Datto, M. B., Shen, X., Hu, P. P., Yu, Y., and Wang, X. F. Sp1, but not Sp3, functions to mediate promoter activation by TGF-β through canonical Sp1 binding sites. Nucleic Acids Res., 26: 2449-2456, 1998.
59. Derynck, R., Zhang, Y., and Feng, X. H. Smads: transcriptional activators of TGF-β responses. Cell, 95: 737-740, 1998.
60. Waf1/Cip1 regulation by transforming growth factor-β J. Biol. Chem., 275: 29244-29256, 2000.
61. Ink4B transcription in response to TGF-β. EMBO J., 19: 5178-5193, 2000.
62. Poncelet, A. C., and Schnaper, H. W. Sp1 and Smad proteins cooperate to mediate transforming growth factor-β-induced α2(1) collagen expression in human glomerular mesangial cells. J. Biol. Chem., 276: 6983-6992, 2001.